The use of the Oxford/AstraZeneca Covid-19 vaccine in vulnerable people may be resulting in a lower death toll in the UK compared to Europe, according to the former chief of the country's vaccine taskforce.
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially "last for life". The Oxford/AstraZeneca jab was approved last December, and vaccines were initially rolled out among the older and the most vulnerable in society.
Mr Dix told The Daily Telegraph: "If you look across Europe, with the rise in cases, there's also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that."He added: "I personally believe that's because most of our vulnerable people were given the